MMA
AZN icon

Miracle Mile Advisors’s AstraZeneca AZN Stock Holding History

Miracle Mile Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.32M Buy
+22,766
New +$4.28M 0.05% 226
2026
Q1 		– Sell
-21,790
Closed -$4.01M – 899
2025
Q4 		$4.01M Buy
21,790
+84
+0.4% +$14.7K 0.06% 219
2025
Q3 		$3.33M Buy
21,706
+388
+2% +$58.7K 0.05% 231
2025
Q2 		$2.98M Buy
21,318
+1,183
+6% +$166K 0.05% 212
2025
Q1 		$2.96M Buy
20,135
+142
+0.7% +$20.5K 0.06% 177
2024
Q4 		$2.62M Buy
19,993
+16,329
+446% +$2.29M 0.05% 194
2024
Q3 		$571K Sell
3,664
-499
-12% -$80.5K 0.01% 351
2024
Q2 		$649K Buy
4,163
+356
+9% +$53.6K 0.02% 320
2024
Q1 		$516K Buy
3,807
+286
+8% +$37.9K 0.01% 345
2023
Q4 		$474K Sell
3,521
-16,489
-82% -$2.14M 0.01% 345
2023
Q3 		$2.71M Sell
20,010
-250
-1% -$34.1K 0.08% 144
2023
Q2 		$2.9M Buy
20,260
+300
+2% +$44.1K 0.09% 146
2023
Q1 		$2.77M Hold
19,960
– – 0.09% 156
2022
Q4 		$2.71M Buy
19,960
+686
+4% +$86K 0.09% 166
2022
Q3 		$2.11M Sell
19,274
-159
-0.8% -$20.2K 0.1% 142
2022
Q2 		$2.57M Sell
19,433
-7
-0% -$918 0.12% 128
2022
Q1 		$2.58M Buy
19,440
+17,502
+903% +$2.1M 0.11% 135
2021
Q4 		$226K Buy
+1,938
New +$228K 0.01% 414

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Miracle Mile Advisors's AZN Position: Q2 2026 in Review

Miracle Mile Advisors opened a new position in AstraZeneca (AZN) in Q2 2026: 22,766 shares worth $4.32M. The stake represents 0.05% of the portfolio and ranks #226 among its holdings. This is a return to the name: Miracle Mile Advisors previously reported a position in AZN as recently as Q4 2025.

Miracle Mile Advisors first reported a position in AZN in Q4 2021 and has held it in 18 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Miracle Mile Advisors held 22,766 shares of AstraZeneca worth $4.32M as of Q2 2026.
  • AstraZeneca was a new Miracle Mile Advisors position in Q2 2026.
  • AstraZeneca made up 0.05% of Miracle Mile Advisors's portfolio in Q2 2026, its #226 holding.
  • Miracle Mile Advisors first reported a position in AstraZeneca in Q4 2021 and has held it in 18 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.